HNN3.0
Register
Register
Register

Project cooperationUpdated on 25 January 2026

Improving the quality of life of cancer patients with innovative natural antioxidant with clinical proven activities

Chief Scientific officer at Algosource

Guérande, France

About

AlgoSource has developed a nutraceutical that is effective in improving the quality of life of cancer patients by improving their general health and decreasing their treatment side effects : PHYCOCARE®. The reduction of oncology side effects using PHYCOCARE® has been observed by several oncologists in France, on human and on animals since 2016. These empirical results have been supported by the demonstration in 2018 of the strong antioxidant activity of the product gained in the PHASE I clinical study SPIROX (double blind against placebo) on 40 subjects. On this basis, the Hospital of Nantes (France) has been convinced to sponsor a clinical study (PROPERTY), to demonstrate a 50 % reduction of Chemotherapy Induced Peripheral Neuropathy (CIPN). We propose to generalize the use of this nutraceutical coupled with other products and innovative care interventions to improve the quality of live of patients aged 65 and more through nutrition.

With already few hospitals involved in the project, we are looking for partners such as specialised food technologist for erderly people, or hospitals with a very strong expertise in nutrition for cancer.

Similar opportunities

  • Project cooperation

    Validated AI-based SAMD to Personalize Post-Hospital Care Pathways in Chronic Heart Failure

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems

    Grégoire MERCIER

    Co-founder at KanopyMed

    Jacou, France

  • Project cooperation

    Paediatric Cancer Centre Barcelona: A Global Reference in Pediatric Oncology

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Mariona Chicón Bosch

    Pre-Award Project Manager at Institut de Recerca Sant Joan de Déu (IRSJD)

    Esplugues de Llobregat, Spain

  • Project cooperation

    Exploring collaboration opportunities

    Vanessa Fanjul Marlé

    International Project Manager at FINBA

    Oviedo, Spain